These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19966059)

  • 1. Compensatory upregulation of the adenosine system following phenylephrine-induced hypertrophy in cultured rat ventricular myocytes.
    Pang T; Gan XT; Freeman DJ; Cook MA; Karmazyn M
    Am J Physiol Heart Circ Physiol; 2010 Feb; 298(2):H545-53. PubMed ID: 19966059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation.
    Gan XT; Taniai S; Zhao G; Huang CX; Velenosi TJ; Xue J; Urquhart BL; Karmazyn M
    Mol Cell Biochem; 2014 Sep; 394(1-2):237-46. PubMed ID: 24894822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes.
    Pang T; Rajapurohitam V; Cook MA; Karmazyn M
    Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1382-90. PubMed ID: 20190100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of phenylephrine-induced cardiomyocyte hypertrophy by activation of multiple adenosine receptor subtypes.
    Gan XT; Rajapurohitam V; Haist JV; Chidiac P; Cook MA; Karmazyn M
    J Pharmacol Exp Ther; 2005 Jan; 312(1):27-34. PubMed ID: 15452191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen exerts concentration-dependent pro-and anti-hypertrophic effects on adult cultured ventricular myocytes. Role of NHE-1 in estrogen-induced hypertrophy.
    Kilić A; Javadov S; Karmazyn M
    J Mol Cell Cardiol; 2009 Mar; 46(3):360-9. PubMed ID: 19111554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct KATP channels mediate the antihypertrophic effects of adenosine receptor activation in neonatal rat ventricular myocytes.
    Xia Y; Javadov S; Gan TX; Pang T; Cook MA; Karmazyn M
    J Pharmacol Exp Ther; 2007 Jan; 320(1):14-21. PubMed ID: 17012605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sestrin 2 attenuates neonatal rat cardiomyocyte hypertrophy induced by phenylephrine via inhibiting ERK1/2.
    Dong B; Xue R; Sun Y; Dong Y; Liu C
    Mol Cell Biochem; 2017 Sep; 433(1-2):113-123. PubMed ID: 28497371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine A1 receptor activation attenuates cardiac hypertrophy and fibrosis in response to α1 -adrenoceptor stimulation in vivo.
    Puhl SL; Kazakov A; Müller A; Fries P; Wagner DR; Böhm M; Maack C; Devaux Y
    Br J Pharmacol; 2016 Jan; 173(1):88-102. PubMed ID: 26406609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-Induced Mitogenic Factor Promotes Cardiac Hypertrophy via Calcium-Dependent and Hypoxia-Inducible Factor-1α Mechanisms.
    Kumar S; Wang G; Liu W; Ding W; Dong M; Zheng N; Ye H; Liu J
    Hypertension; 2018 Aug; 72(2):331-342. PubMed ID: 29891648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Miro1 as a novel regulator of hypertrophy in neonatal rat cardiomyocytes.
    Conejeros C; Parra V; Sanchez G; Pedrozo Z; Olmedo I
    J Mol Cell Cardiol; 2020 Apr; 141():65-69. PubMed ID: 32234389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes.
    Barron AJ; Finn SG; Fuller SJ
    Biochem J; 2003 Apr; 371(Pt 1):71-9. PubMed ID: 12513686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginseng inhibits cardiomyocyte hypertrophy and heart failure via NHE-1 inhibition and attenuation of calcineurin activation.
    Guo J; Gan XT; Haist JV; Rajapurohitam V; Zeidan A; Faruq NS; Karmazyn M
    Circ Heart Fail; 2011 Jan; 4(1):79-88. PubMed ID: 20971938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of α-enolase protects cardiomyocytes from phenylephrine-induced hypertrophy.
    Gao S; Liu XP; Wei LH; Lu J; Liu P
    Can J Physiol Pharmacol; 2018 Apr; 96(4):352-358. PubMed ID: 28910549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin suppresses phenylephrine-induced hypertrophic responses by inhibiting p300-HAT activity in cardiomyocytes.
    Sunagawa Y; Shimizu K; Katayama A; Funamoto M; Shimizu K; Nurmila S; Shimizu S; Miyazaki Y; Katanasaka Y; Hasegawa K; Morimoto T
    J Pharmacol Sci; 2021 Oct; 147(2):169-175. PubMed ID: 34384564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polydatin prevents hypertrophy in phenylephrine induced neonatal mouse cardiomyocytes and pressure-overload mouse models.
    Dong M; Ding W; Liao Y; Liu Y; Yan D; Zhang Y; Wang R; Zheng N; Liu S; Liu J
    Eur J Pharmacol; 2015 Jan; 746():186-97. PubMed ID: 25449040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertrophic Effects of Nebivolol on Neonatal Cardiomyocyte Hypertrophy Models.
    Ozakca I
    J Cardiovasc Pharmacol; 2019 Mar; 73(3):155-164. PubMed ID: 30601193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RGS2 is upregulated by and attenuates the hypertrophic effect of alpha1-adrenergic activation in cultured ventricular myocytes.
    Zou MX; Roy AA; Zhao Q; Kirshenbaum LA; Karmazyn M; Chidiac P
    Cell Signal; 2006 Oct; 18(10):1655-63. PubMed ID: 16517124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cross talk between corticosteroids and alpha-adrenergic signalling augments cardiomyocyte hypertrophy: a possible role for SGK1.
    Lister K; Autelitano DJ; Jenkins A; Hannan RD; Sheppard KE
    Cardiovasc Res; 2006 Jun; 70(3):555-65. PubMed ID: 16533503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Jun N-terminal kinase-interacting protein 1 inhibits gene expression in response to hypertrophic agonists in neonatal rat ventricular myocytes.
    Finn SG; Dickens M; Fuller SJ
    Biochem J; 2001 Sep; 358(Pt 2):489-95. PubMed ID: 11513749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of RhoA activation and cofilin-mediated actin polymerization mediates the antihypertrophic effect of adenosine receptor agonists in angiotensin II- and endothelin-1-treated cardiomyocytes.
    Zeidan A; Gan XT; Thomas A; Karmazyn M
    Mol Cell Biochem; 2014 Jan; 385(1-2):239-48. PubMed ID: 24096734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.